Terms: = Gastric cancer AND KAT6B, DKFZp313G1618, 23522, MYST4, ENSG00000156650, Q8WYB5, querkopf, qkf, MOZ2, MORF, KIAA0383, FLJ90335
3 results:
1. circUBAP2 inhibits cisplatin resistance in gastric cancer via miR-300/kat6b axis.
Cheng W; Luan P; Jin X
Anticancer Drugs; 2023 Jan; 34(1):126-134. PubMed ID: 36206113
[TBL] [Abstract] [Full Text] [Related]
2. CircKIAA0907 Retards Cell Growth, Cell Cycle, and Autophagy of gastric cancer In Vitro and Inhibits Tumorigenesis In Vivo via the miR-452-5p/kat6b Axis.
Zhu L; Wang C; Lin S; Zong L
Med Sci Monit; 2020 Jul; 26():e924160. PubMed ID: 32722658
[TBL] [Abstract] [Full Text] [Related]
3. MicroRNA-4513 Promotes gastric cancer Cell Proliferation and Epithelial-Mesenchymal Transition Through Targeting kat6b.
Ding H; Shi Y; Liu X; Qiu A
Hum Gene Ther Clin Dev; 2019 Sep; 30(3):142-148. PubMed ID: 31310159
[TBL] [Abstract] [Full Text] [Related]
